Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual
How can DMT be improved to better treat addiction? How do our genetics influence our
Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke
Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke
After his brother overdosed in 2019, Timothy Ko founded Entheon Biomedical (ENBI) on his quest
Core One Labs Now Also Working to Biosynthesize DMT and Receives License Vancouver, British Columbia,
Mycrodose Therapeutics Receives DEA License to Research Four Psychedelics Mycrodose Therapeutics is pleased to announce that
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs Entheon Biomedical (ENBI) has begun
Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs Entheon Biomedical (ENBI) has begun
Ayahuasca users report psychological benefits after taking placebo at a ritualistic ceremony An ayahuasca retreat
Way2Grow (W2G) Biopharma Corp. Receives Health Canada Approval Notice for Construction of a Controlled Substances
Discussions With FDA Provide Guidance For Phase IIb Clinical Trial Design For DMT-assisted Therapy For
DEA Boosts Psilocybin, MDMA And DMT Production Levels Again In Final Quotas For 2021 To
DMT and PTSD In honour of Veteran’s Day, we’re sharing the story of how a
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases PharmaDrug narrows list
Understanding Neuroplasticity Induced by TrYptamines (UNITY) Psychedelics clearly have a huge impact on people with
Small Pharma granted fast-track designation from UK regulator for DMT-assisted therapy for Major Depressive Disorder
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub
Blue Sun Mycology Group Announces Filing of 2 US Patents for Methods Related to Inventing
